Zoetis Boosts FY24 Outlook As Q2 Results Top Estimates

RTTNews | 259 days ago
Zoetis Boosts FY24 Outlook As Q2 Results Top Estimates

(RTTNews) - While reporting financial results for the second quarter on Tuesday, animal health company Zoetis, Inc. (ZTS) raised its earnings, adjusted earnings and revenue guidance for the full year 2024.

For fiscal 2024, the company continues to project earnings in a range of $5.35 to $5.45 per share and adjusted earnings in a range of $5.78 to $5.88 per share on revenues between $9.10 billion and $9.25 billion, with operational revenue growth of 9 to 11 percent.

Previously, the company expected earnings in a range of $5.34 to $5.44 per share and adjusted earnings in a range of $5.71 to $5.81 per share on revenues between $9.05 billion and $9.20 billion, with operational revenue growth of 8.5 to 10.5 percent.

On average, 16 analysts polled by Thomson Reuters expect the company to report earnings of $5.77 per share on revenues of $9.15 billion for the year. Analysts' estimates typically exclude special items.

For the second quarter, the company reported net income attributable to Zoetis of $624 million or $1.37 per share, down from $671 million or $1.45 per share in the prior-year quarter.

Excluding items, adjusted earnings for the quarter were $1.56 per share, compared to $1.41 per share in the year-ago quarter.

Revenue for the quarter grew 8 percent to $2.36 billion from $2.18 billion in the same quarter last year. On an operational basis, revenue increased 11 percent, excluding the impact of foreign currency.

The Street was looking for earnings of $1.49 per share on revenues of $2.31 billion for the quarter.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

read more
Zoetis Again Slashes FY22 Outlook As Q3 Results Miss Estimates; Stock Down 11%

Zoetis Again Slashes FY22 Outlook As Q3 Results Miss Estimates; Stock Down 11%

While reporting financial results for the third quarter on Thursday, animal health company Zoetis Inc. (ZTS) again slashed its earnings, adjusted earnings and revenue guidance for the full year 2022, to reflect lower than expected sales due to continued supply constraints, veterinary workforce challenges, as well as the negative impact of recent changes to foreign exchange rates.
RTTNews | 901 days ago
Roche To Invest $50 Bln In U.S; To Create 12,000 Jobs

Roche To Invest $50 Bln In U.S; To Create 12,000 Jobs

Amid the ongoing tariff issues, Swiss drug major Roche Holding AG announced its plan to invest $50 billion in the United States in the next five years, aiming to expand its Pharmaceutical and Diagnostics Divisions. With all new and expanded manufacturing capacity, Roche aims to export more medicines from the US than it imports.
RTTNews | 3h 10min ago
Bay Street Likely To Open On Cautious Note

Bay Street Likely To Open On Cautious Note

The Canadian market is likely to open on a cautious note Tuesday morning, but some buying is likely in energy and materials sectors thanks to firm commodity prices. Worries about trade tensions and the stand-off between U.S. President and the Fed Chair might hurt sentiment and limit market's upside.
RTTNews | 3h 11min ago
FTSE 100 Up Marginally; Sainsbury Rises After Announcing Buyback Program

FTSE 100 Up Marginally; Sainsbury Rises After Announcing Buyback Program

U.K. stocks are modestly higher on Tuesday, led by gains in retailers and consumer staples stocks, even as the mood remains cautious amid lingering concerns about global economic growth due to trade tensions following the U.S. government's highly protectionist trade policy.
RTTNews | 4h 56min ago